287 related articles for article (PubMed ID: 9554336)
21. Long-term results of sacral neuromodulation with the tined lead procedure.
Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG
J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820
[TBL] [Abstract][Full Text] [Related]
22. Sacral nerve stimulation in patients with chronic intractable pelvic pain.
Siegel S; Paszkiewicz E; Kirkpatrick C; Hinkel B; Oleson K
J Urol; 2001 Nov; 166(5):1742-5. PubMed ID: 11586214
[TBL] [Abstract][Full Text] [Related]
23. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience.
Spinelli M; Giardiello G; Gerber M; Arduini A; van den Hombergh U; Malaguti S
J Urol; 2003 Nov; 170(5):1905-7. PubMed ID: 14532804
[TBL] [Abstract][Full Text] [Related]
24. Sacral neuromodulation for lower urinary tract dysfunction and impact on erectile function.
Lombardi G; Mondaini N; Giubilei G; Macchiarella A; Lecconi F; Del Popolo G
J Sex Med; 2008 Sep; 5(9):2135-40. PubMed ID: 18637993
[TBL] [Abstract][Full Text] [Related]
25. The role of the carbachol test and concomitant diseases in patients with nonobstructive urinary retention undergoing sacral neuromodulation.
Bross S; Braun PM; Weiss J; Martinez Portillo FJ; Knoll T; Seif C; Juenemann KP; Alken P
World J Urol; 2003 May; 20(6):346-9. PubMed ID: 12811494
[TBL] [Abstract][Full Text] [Related]
26. Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method?
Kessler TM; Madersbacher H; Kiss G
Eur Urol; 2005 May; 47(5):660-5. PubMed ID: 15826759
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of sacral neuromodulation in treatment of bladder pain syndrome: long-term follow-up.
Ghazwani YQ; Elkelini MS; Hassouna MM
Neurourol Urodyn; 2011 Sep; 30(7):1271-5. PubMed ID: 21557299
[TBL] [Abstract][Full Text] [Related]
28. The presence of Fowler's syndrome predicts successful long-term outcome of sacral nerve stimulation in women with urinary retention.
De Ridder D; Ost D; Bruyninckx F
Eur Urol; 2007 Jan; 51(1):229-33; discussion 233-4. PubMed ID: 16860462
[TBL] [Abstract][Full Text] [Related]
29. Canadian experience in sacral neuromodulation.
Elkelini M; Hassouna MM
Urol Clin North Am; 2005 Feb; 32(1):41-9. PubMed ID: 15698875
[TBL] [Abstract][Full Text] [Related]
30. Transcutaneous electrical nerve stimulation and temporary S3 neuromodulation in idiopathic detrusor instability.
Hasan ST; Robson WA; Pridie AK; Neal DE
J Urol; 1996 Jun; 155(6):2005-11. PubMed ID: 8618309
[TBL] [Abstract][Full Text] [Related]
31. The relationship between subjective and objective assessments of sacral neuromodulation effectiveness in patients with urgency-frequency.
Peters KM; Killinger KA; Ibrahim IA; Villalba PS
Neurourol Urodyn; 2008; 27(8):775-8. PubMed ID: 18551573
[TBL] [Abstract][Full Text] [Related]
32. Improvement in depression and health-related quality of life after sacral nerve stimulation therapy for treatment of voiding dysfunction.
Das AK; Carlson AM; Hull M;
Urology; 2004 Jul; 64(1):62-8. PubMed ID: 15245937
[TBL] [Abstract][Full Text] [Related]
33. Unilateral versus bilateral stage I neuromodulator lead placement for the treatment of refractory voiding dysfunction.
Pham K; Guralnick ML; O'Connor RC
Neurourol Urodyn; 2008; 27(8):779-81. PubMed ID: 18551562
[TBL] [Abstract][Full Text] [Related]
34. Urethral instability and sacral nerve stimulation-a better parameter to predict efficacy?
Groenendijk PM; Heesakkers JP; Lycklama A Nijeholt AA
J Urol; 2007 Aug; 178(2):568-72; discussion 572. PubMed ID: 17570438
[TBL] [Abstract][Full Text] [Related]
35. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.
Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE
Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317
[TBL] [Abstract][Full Text] [Related]
36. Sacral neuromodulation in urological indications: the Finnish experience.
Vaarala MH; Tammela TL; Perttilä I; Luukkonen P; Hellström P
Scand J Urol Nephrol; 2011 Feb; 45(1):46-51. PubMed ID: 20961268
[TBL] [Abstract][Full Text] [Related]
37. Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence.
Groenendijk PM; Lycklama à Nyeholt AA; Heesakkers JP; van Kerrebroeck PE; Hassouna MM; Gajewski JB; Cappellano F; Siegel SW; Fall M; Dijkema HE; Jonas U; van den Hombergh U;
BJU Int; 2008 Feb; 101(3):325-9. PubMed ID: 18070199
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction.
Peeters K; Sahai A; De Ridder D; Van Der Aa F
BJU Int; 2014 May; 113(5):789-94. PubMed ID: 24238278
[TBL] [Abstract][Full Text] [Related]
39. Preliminary results of sacral neuromodulation in 23 children.
Humphreys MR; Vandersteen DR; Slezak JM; Hollatz P; Smith CA; Smith JE; Reinberg YE
J Urol; 2006 Nov; 176(5):2227-31. PubMed ID: 17070300
[TBL] [Abstract][Full Text] [Related]
40. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.
Ghalayini IF; Al-Ghazo MA; Pickard RS
BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
